BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28970467)

  • 1. Systemic Mastocytosis in Association with Small Lymphocytic Lymphoma.
    Iqbal MF; Soriano PMK; Nagendra S; Sana S
    Am J Case Rep; 2017 Oct; 18():1053-1057. PubMed ID: 28970467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
    Horny HP; Sotlar K; Stellmacher F; Valent P; Grabbe J
    J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
    Hauswirth AW; Födinger M; Fritz M; Müllauer L; Simonitsch-Klupp I; Streubel B; Chott A; Sperr WR; Jäger U; Valent P
    Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
    Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
    Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis associated with small lymphocytic lymphoma: an incidental finding in a patient with invasive gastric adenocarcinoma.
    Steinmetz C; Shabaik A; Hasteh F
    Diagn Cytopathol; 2007 Nov; 35(11):728-33. PubMed ID: 17924405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.
    Horny HP; Lange K; Sotlar K; Valent P
    J Clin Pathol; 2003 Aug; 56(8):575-8. PubMed ID: 12890804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
    Kim Y; Weiss LM; Chen YY; Pullarkat V
    Leuk Res; 2007 Dec; 31(12):1749-54. PubMed ID: 17544505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.
    Du S; Rashidi HH; Le DT; Kipps TJ; Broome HE; Wang HY
    Int J Clin Exp Pathol; 2010 Apr; 3(4):448-57. PubMed ID: 20490336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.
    Stoecker MM; Wang E
    Arch Pathol Lab Med; 2012 Jul; 136(7):832-8. PubMed ID: 22742558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
    Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
    Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
    Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
    Ault P; Lynn A; Tam CS; Medeiros LJ; Keating MJ
    Leuk Res; 2007 Dec; 31(12):1755-8. PubMed ID: 17521719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
    Horny HP; Sotlar K; Sperr WR; Valent P
    J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
    Zheng Y; Nong L; Liang L; Wang W; Li T
    Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The international consensus classification of mastocytosis and related entities.
    Leguit RJ; Wang SA; George TI; Tzankov A; Orazi A
    Virchows Arch; 2023 Jan; 482(1):99-112. PubMed ID: 36214901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic mastocytosis presenting with a prominent B lymphocyte proliferation in the bone marrow and extensive fibrosis of the spleen.
    Neşe N; Cagirgan S; Ertan Y; Sönmez A; Soydan S; Hekimgil M
    Dis Markers; 2007; 23(3):167-71. PubMed ID: 17473386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.